New York Bone & Joint Specialists: New Invention Stops or Delays the Progression of Osteoarthritis of the Knee

April 1, 2021

New York Bone & Joint Specialists is at the forefront of orthopedic technology, with an exciting invention focused on preventing the development and/or progression of osteoarthritis of the knee.

At the same time, this invention can be used to promote and accelerate the healing of any orthopedically repaired tissue.

Leon E. Popovitz, MD, co-founder of New York Bone & Joint Specialists and top orthopedic surgeon in NYC, has invented a bone and joint implant device that has the potential to counteract the effects of osteoarthritis. As a result, the device would diminish the need for joint replacement surgery, and save billions of dollars in medical costs.

The invention is an anchor that increases blood circulation to soft tissue. It features a unique network of channels that are designed to maximize blood flow and rejuvenate vital structures, such as the meniscus, in a degenerating knee. Thus, a patient who suffers from the beginnings of osteoarthritis of the knee may completely avoid the long and painful process of managing their deteriorating joint and eventually receiving a knee replacement. Instead, their knee may become rejuvenated without the need for joint replacement surgery.

Dr. Popovitz and his team have completed bench testing and cadaver intraoperative testing for this patented implant. Further studies are still in process.

“Millions of people suffer from knee osteoarthritis and millions undergo extensive joint replacement therapy,” says Dr. Popovitz. “My implant serves to replenish circulation to the meniscus, which functions by protecting the knee joint from degeneration. The invention, therefore, works by preserving the knee joint itself.”

Hot this week

Avery Dennison Medical Introduces Ipdated SilFoam Lite: Sustainability, MDR Certification & Performance Improvements

The newly enhanced SilFoam Lite delivers superior efficiency and reliability, bringing improved fluid handling capabilities and improved tack. These improvements make the product ideal for customers seeking quality, high-performance solutions in wound care notes Avery Dennison Medical.

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMedâ„¢ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.